Therapeutic opportunities within the DNA damage response

Pearl, Laurence H., Schierz, Amanda C., Ward, Simon E., Al-Lazikani, Bissan, Pearl, Frances M. G.·2015·Nature Reviews Cancer

DOI 10.1038/nrc3891

Cited by (578)

Items 301–400 of 578

Structural characterization of the redefined DNA-binding domain of human XPA
Fuming Lian, Xiangwei Yang, Wancai Yang, Yong‐Liang Jiang, Chengmin Qian · 2019 · Biochemical and Biophysical Research Communications
VHL Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 Screens
Ning Sun, Sakina M. Petiwala, Charles Lu, Jessica E. Hutti, Min Hu, Mufeng Hu, Marc H. Domanus, Diya Mitra, Sadiya N. Addo, Christopher P. Miller et al. · 2019 · The CRISPR Journal
RNA in DNA repair
Cathrine Broberg Vågbø, Geir Slupphaug · 2020 · DNA repair
1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G2/M phase
Chun Peng, Xinming Qi, Lingling Miao, Jin Ren · 2017 · Acta Pharmacologica Sinica
Challenges and Opportunities of Gene Therapy in Cancer
Milky Mittal, Annu Kumari, Bhashkar Paul, Adya Varshney, Bhavya Bhavya, Ashok Saini, Chaitenya Verma, Indra Mani · 2024 · OBM Genetics
Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge
David Anthony Skerrett-Byrne, Simone J. Stanger, Natalie A. Trigg, Amanda L. Anderson, Petra Sipilä, Ilana R. Bernstein, Tessa Lord, John Even Schjenken, Heather C. Murray, Nicole M. Verrills et al. · 2024 · Andrology
Genotoxic consequences of viral infections
Olga Klaudia Szewczyk-Roszczenko, Piotr Roszczenko, Yegor S Vassetzky, Nikolajs Sjakste · 2025 · npj Viruses
Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR–p53–NF-κB interactions
Minsu Kwon, Hye-Jin Jang, Eun Hye Kim, Jong‐Lyel Roh · 2016 · Cell Cycle
Distinct roles of structure-specific endonucleases EEPD1 and Metnase in replication stress responses
Neelam Sharma, Michael Clayton Speed, Chris Allen, David G. Maranon, Elizabeth A. Williamson, Sudha Singh, Robert Hromas, Jac A. Nickoloff · 2020 · NAR Cancer
Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer
Lin Wang, Xueping Li, Lan Zhao, Longyang Jiang, Xinyue Song, Aoshuang Qi, Ting Chen, Baohui Hu, Baohui Hu, Minjie Wei et al. · 2021 · Pathology & Oncology Research
Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
Qiaoling Liu, Qi Xiao, Zhen Sun, Bo Wang, Lina Wang, Na Wang, Kai Wang, Chengli Song, Qingkai Yang · 2021 · eLife
Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations
Chenyue Zhang, Haiyong Wang · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumors
Hani M. Babiker, Ali McBride, Laurence S. Cooke, Daruka Mahadevan · 2017 · Expert Opinion on Investigational Drugs
The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance
Mara Zippoli, Anna Ruocco, Rubina Novelli, Francesca Rocchio, Martina Sara Miscione, Marcello Allegretti, Maria Candida Cesta, Pier Giorgio Amendola · 2022 · Frontiers in Oncology
MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapy
Vincent W S Leong, Sabbir Khan, Pratibha Sharma, Shaofang Wu, Riya Thomas, Xiaolong Li, Sanjay Kumar Singh, Frederick F. Lang, Alfred W. K. Yung, Dimpy Koul · 2023 · Neuro-Oncology Advances
What Combined Measurements From Structures and Imaging Tell Us About DNA Damage Responses
Chris A. Brosey, Zamal Ahmed, Susan P. Lees‐Miller, John A. Tainer · 2017 · Methods in enzymology on CD-ROM/Methods in enzymology
The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis
Wang Yan, Zhisheng Wu · 2021 · Frontiers in Oncology
Metabolic remodeling maintains a reducing environment for rapid activation of the yeast DNA replication checkpoint
Lili Li, Jie Wang, Zijia Yang, Yiling Zhao, Hui Jiang, Luguang Jiang, Wenya Hou, Risheng Ye, Qun He, Martin Kupiec et al. · 2022 · The EMBO Journal
The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways
Esraa Almalki, Abdullah Al-Amri, Reem Alrashed, Mohammed Mousa Al-Zharani, Abdelhabib Semlali · 2023 · International Journal of Molecular Sciences
Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy
Zhuang Zhu, Shaoming Li, Xiaopeng Yin, Kai Sun, Jianzhong Song, Wenhao Ren, Ling Gao, Keqian Zhi · 2024 · International Journal of Biological Macromolecules
Activation of DNA Damage Response Induced by the Kaposi’s Sarcoma-Associated Herpes Virus
Enea Gino Di Domenico, Luigi Toma, Valentina Bordignon, Elisabetta Trento, Giovanna D’Agosto, Paola Cordiali‐Fei, Fabrizio Ensoli · 2016 · International Journal of Molecular Sciences
Functional characterization of Candida glabrata ORF, CAGL0M02233g for its role in stress tolerance and virulence
Payal Gupta, R C Meena, Navin Kumar · 2020 · Microbial Pathogenesis
A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance
Yingguang Li, Kexin Yue, Linrong Li, Jie Niu, Hanfang Liu, Jing Ma, Songqiang Xie · 2020 · Bioorganic Chemistry
Targeting DNA Damage Response and Immune Crosstalk in Cancer: Mechanistic Insights and Therapeutic Opportunities
Lavinia Florica Mărcuț, Roxana Daniela Brata, Alina Cristina Barb, Alexia Manole, Dan Gabriel Stef, Cristina Ștefania Dumitru, Flavia Zara, Raul Pătrașcu · 2025 · International Journal of Molecular Sciences
Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma
Álvaro González-Rajal, Jordan F. Hastings, D. Neil Watkins, David R. Croucher, Andrew Burgess · 2020 · Frontiers in Cell and Developmental Biology
Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing
Joanna Lopacinska‐Jørgensen, Douglas V.N.P. Oliveira, Tim Svenstrup Poulsen, Claus Kim Høgdall, Estrid Vilma Solyom Høgdall · 2023 · Anticancer Research
TRAIP regulates Histone�H2B monoubiquitination in DNA damage response pathways
Ye Han, Miyong Yun, Minji Choi, Seok‐Geun Lee, Hongtae Kim · 2019 · Oncology Reports
Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease
Jennifer Q. J. Zhang, Sayanthooran Saravanabavan, Gopala K. Rangan · 2021 · Cells
Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma
Xiaohui Wu, Haijia Tang, Wenhao Xu, Haidan Tang, Shiyin Wei, Aihetaimujiang Anwaier, Haineng Huang, Yuanyuan Qu, Hailiang Zhang, Shuai Zhao et al. · 2021 · Frontiers in Genetics
New structural insights into the recognition of undamaged splayed-arm DNA with a single pair of non-complementary nucleotides by human nucleotide excision repair protein XPA
Fuming Lian, Xiangwei Yang, Yong‐Liang Jiang, Feng Yang, Changlin Li, Wancai Yang, Chengmin Qian · 2020 · International Journal of Biological Macromolecules
Haplotype-resolved germline and somatic alterations in renal medullary carcinomas
K.T. Tan, Hyun‐Ji Kim, Jian Carrot‐Zhang, Yuxiang Zhang, Won Jun Kim, Guillaume Kugener, Jeremiah A. Wala, Thomas P. Howard, Yueh-Yun Chi, Rameen Beroukhim et al. · 2021 · Genome Medicine
Targeting the DNA damage response in hematological malignancies
Sanjay De Mel, Ainsley Ryan Yan Bin Lee, Joelle Hwee Inn Tan, Rachel Tan, Limei Michelle Poon, Esther Hian Li Chan, Joanne Lee, Yen Lin Chee, Satish R. Lakshminarasappa, Patrick William Jaynes et al. · 2024 · Frontiers in Oncology
Discovery of the Clinical Candidate YY2201 as a Highly Potent and Selective ATR Inhibitor
Meng Yin Wu, Xiaofang Chen, Haoran Wang, Chang Li, Wenjing Liu, Xiao Zheng, Jingxin Yang, Xin Ye, Yali Weng, Tianyun Fan et al. · 2025 · Journal of Medicinal Chemistry
Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns
Simon Grund Sørensen, Amruta Shrikhande, Gustav Alexander Poulsgaard, Mikkel Hovden Christensen, Johanna Bertl, Britt Elmedal Laursen, Eva R. Hoffmann, Jakob Skou Pedersen · 2023 · eLife
DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities
Ning Zhao, Zicheng Zhang, Qiang Wang, Lin Li, Zichao Wei, Hongyan Chen, Meng Zhou, Zhihua Liu, Jianzhong Su · 2023 · EBioMedicine
BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening.
Jie Ding, Shaofang Wu, Chen Zhang, Arnav Garyali, Emmanuel Martínez-Ledesma, Feng Gao, Adarsha Pokkulandra, Xiaolong Li, Christopher Aaron Bristow, Alessandro Carugo et al. · 2019 · PubMed Central
Mechanistic insight of cyclin-dependent kinase 5 in modulating lung cancer growth
Ho Lin, Mei‐Chih Chen, G. M. Shazzad Hossain Prince, Tsung‐Ying Yang · 2019 · The Chinese Journal of Physiology
Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma
Xianxian Sui, Can-Jing Zhang, Yudong Jiang, Jianan Zhou, Chen Xu, Feng Ru Tang, Bobin Chen, Huiwen Xu, Songmei Wang, Xuanyi Wang · 2020 · Annals of Translational Medicine
DNA damage response and repair in pancreatic cancer development and therapy
Parnia Rahnamay Farnood, Romina Danesh Pazhooh, Zatollah Asemi, Bahman Yousefi · 2021 · DNA repair
Characterization of DNA damage response deficiency in pancreatic cancer patients from China
Xiaofei Zhang, Tiebo Mao, Bei Zhang, Haiyan Xu, Jiujie Cui, Feng Jiao, Dongqin Chen, Yu Wang, Jiong Hu, Qing Xia et al. · 2021 · 癌症：英文版
Aurora kinase B phosphorylates ZBP1 to drive PANoptosis following treatment with PARP and ATR inhibitors combination
Wenjian Gong, Zhiqi Liao, Fan Xiong, Linghui Wang, Shen-Nan Shi, Mengshi Luo, Yuewen Zhang, Qiuyang Xu, Yuanyuan Wang, Yijie Wu et al. · 2025 · Nature Communications
DNA damage response as a therapeutic target in gynecological cancers
Alexandra F. Leary, Aurélie Auguste, Soizick Jeanne Lynette Mesnage · 2016 · Current Opinion in Oncology
Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas
Alexandra R. Buckley, Trey Ideker, Hannah K. Carter, Olivier Harismendy, Nicholas J. Schork · 2018 · Genome Medicine
MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric Cancer
Tao Wang, Peng Zhang, Chengguo Li, Weizhen Liu, Qian Shen, Lei Yang, Gengchen Xie, Jie Bai, Ruidong Li, Kaixiong Tao et al. · 2022 · Frontiers in Oncology
Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?
Chao Yin, Monika Kulasekaran, Tina Roy, Brennan James Decker, Sonja Alexander, Matthew L. Margolis, Reena C. Jha, Gary M. Kupfer, Aiwu Ruth He · 2022 · Cancers
A novel DNA damage and repair‐related gene signature to improve predictive capacity of overall survival for patients with gliomas
Xiaodong Li, Yichang Wang, Wei Wu, Jianyang Xiang, Maode Wang, Hai Yu · 2022 · Journal of Cellular and Molecular Medicine
Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma
Narayan Acharya, Kamaleshwar P. Singh · 2022 · WIREs Mechanisms of Disease
The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome
Thomas D. J. Walker, Zahra Faraahi, Marcus J. Price, Amy Hawarden, Caitlin A. Waddell, Bryn Russell, Dominique M. Jones, Aiste McCormick, N. Gavrielides, S. Tyagi et al. · 2023 · British Journal of Cancer
Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents
Huimin Li, Jia Yu, Gang Yu, Sha Cheng, Hui Wu, Jiaomei Wei, Chang You, Kun Liu, Menghan Wang, Xueling Meng et al. · 2024 · Molecular Diversity
Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Fereshteh Izadi, Benjamin P. Sharpe, Stella Panagio Breininger, Maria Secrier, Jane Gibson, Robert Walker, Saqib Rahman, Ginny Devonshire, Megan A. Lloyd, Zoë S. Walters et al. · 2021 · Cancers
Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer
Ami G. Sangster, Robert J Gooding, Andrew Garven, Hamid Ghaedi, David Monty Berman, Scott K. Davey · 2022 · PLoS ONE
‘Big data’ approaches for novel anti-cancer drug discovery
Graeme Benstead-Hume, Sarah K. Wooller, Frances M. G. Pearl · 2017 · Expert Opinion on Drug Discovery
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for
Sara Parola, Christoph Oing, Pasquale Rescigno, Salvatore Feliciano, Francesca Carlino, Luca Pompella, Antonella Lucia Marretta, Irene De Santo, Martina Viggiani, Margherita Muratore et al. · 2024 · Frontiers in Genetics
The cold immunological landscape of ATM-deficient cancers
Sonali Sinha, Victor Ng, Ardijana Novaj, Yingjei Zhu, Shu Yazaki, Xin Pei, Fatemeh N. Derakhshan, Fresia G. Pareja, Jeremy S. Setton, Flavie Naulin et al. · 2025 · Journal for ImmunoTherapy of Cancer
Oncometabolites as Regulators of DNA Damage Response and Repair
Susan E. Gueble, Ranjit S. Bindra · 2021 · Seminars in Radiation Oncology
DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
Xiao Jing, Xiangcheng Qin, Hao Liu, Huanhuan Liu, Huina Wang, Jiayue Qin, Yanui Zhang, Shanbo Cao, Xiaodong Fan · 2024 · European journal of medical research
Methods for Assessing DNA Repair and Repeat Expansion in Huntington’s Disease
Thomas H. Massey, Branduff McAllister, Lesley Jones · 2018 · Methods in molecular biology
Proguanil synergistically sensitizes ovarian cancer cells to olaparib by increasing DNA damage and inducing apoptosis
Yan Wu, Tianyu Wu, Xin Hu, Simeng Xu, Di Xiao, Jingtao Wu, Xinjian Yan, Xiaoping Yang, Gaofeng Li · 2022 · International Journal of Medical Sciences
Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics
Shuai Ma, Jieyou Zhang, Qiushi Guo, Cheng Cao, Kaiwen Bao, Ling Liu, Charlie Degui Chen, Zhe Liu, Jie Yang, Na Yang et al. · 2022 · Cancer Letters
Targeting homologous recombination repair in cancer
Ivana Murfuni, Ulrich Rass · 2016 · Elsevier eBooks
Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance
Vassilios Myrianthopoulos, Olivier Lozach, Danae Zareifi, Leonidas G. Alexopoulos, Laurent Meijer, Vassilis G. Gorgoulis, Emmanuel Mikros · 2017 · International Journal of Molecular Sciences
DNA Damage Repair Pathways and Repair of Cisplatin-Induced DNA Damage
Zhigang Wang, Guangyu Zhu · 2018 · Elsevier eBooks
TRIM37–PARP1–TET1 axis maintains stemness and prevents osteoporosis by inhibiting DNMT1 alternative splicing via 5hmC regulation
Chun-Te Ho, Ling‐Hui Li, Wei‐Chao Chang, Heng‐Hsiung Wu, Ya-Huey Chen, Shih‐Chieh Hung · 2025 · Nature Communications
Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients.
Magdalena Markowska, Magdalena A. Budzinska, Anna M. L. Coenen-Stass, Senbai Kang, Ewa Kizling, Krzysztof Kolmus, Krzysztof Koras, Eike Staub, Ewa Szczurek · 2023 · Scientific Reports
In silico identification of inhibitors targeting N-Terminal domain of human Replication Protein A
Süleyman Selim Çınaroğlu, Emel Timuçin · 2018 · Journal of Molecular Graphics and Modelling
Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma
Yi Chen, Mengjia Huang, Junkai Zhu, Li Xu, Wenxuan Cheng, Xiaofan Lu, Fangrong Yan · 2022 · Frontiers in Pharmacology
Radiosensitizing effect of dendrosomal nanoformulation of curcumin on cancer cells
Tahereh Jalali Varnamkhasti, Meisam Jafarzadeh, Majid Sadeghizadeh, Mahdi Aghili · 2022 · Pharmacological Reports
Identification of a novel human DNA ligase I inhibitor that promotes cellular apoptosis in DLD-1 cells: an in silico and in vitro mechanistic study
Deependra Kumar Singh, Mohd Kamil Hussain, Shagun Krishna, Amit Laxmikant Deshmukh, Mohammad Shameem, Pooja Maurya, Kanchan Hajela, Mohammad Imran Siddiqi, Dibyendu Banerjee · 2016 · RSC Advances
Single drug biomarker prediction for ER− breast cancer outcome from chemotherapy
Yongzi Chen, Youngchul Kim, Hatem Hussein Soliman, Guoguang Ying, Jae K. Lee · 2018 · Endocrine Related Cancer
A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes
Ying‐Cheng Chiang, Po‐Han Lin, Tzu‐Pin Lu, Kuan‐Ting Kuo, Yi‐Jou Tai, Heng‐Cheng Hsu, Chia‐Ying Wu, Chia‐Yi Lee, Hung Shen, Chi‐An Chen et al. · 2021 · Biomedicines
Regulatory perspectives of nanomaterials for theranostic application
Faraat Ali · 2022 · Elsevier eBooks
A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma
Xiongtao Yang, Guohui Wang, Runchuan Gu, Xiaohong Xu, Guangying Zhu · 2020 · PeerJ
Targeting the DNA damage response to enhance radiotherapy in soft tissue sarcomas
Bauke H.G. van Riet, Sanne Venneker, Judith V.M.G. Bovée, Neeltje Steeghs, Rick L. Haas · 2025 · Critical Reviews in Oncology/Hematology
DNA damage and repair in cardiomyopathy: mechanisms and therapeutic opportunities
Xiaohai Zhou, Zhe Yu, Zeyu Chen, Sylvia Μ. Evans, Ju Chen · 2025 · American Journal of Physiology-Heart and Circulatory Physiology
Impaired Integrated Stress Response and Mitochondrial Integrity Modulate Genotoxic Stress Impact and Lower the Threshold for Immune Signalling
Mihaela Temelie, Rubab Talpur, Marta Domínguez-Prieto, Ayanda Dantas Silva, Constantin Cenușă, Liviu Stefan Craciun, Diana Savu, Nicoleta Moisoi · 2023 · International Journal of Molecular Sciences
ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway
Hao Yang, K Huebner, Chuanpit Hampel, Katharina Erlenbach‐Wuensch, Selva Babu Selvamani, Vikas Shukla, Carol Imanuel Geppert, Arndt Hartmann, Vijayalakshmi Mahadevan, Regine Schneider‐Stock · 2023 · BMC Cancer
SART3 promotes homologous recombination repair by stimulating DNA-RNA hybrids removal and DNA end resection
Hui Fu, Min Huang, Honglin Wu, Hui Zheng, Yifei Gong, Lingyu Xing, Juanjuan Gong, Ruiyuan An, Qian Li, Xinyu Jie et al. · 2025 · Nature Communications
An Asynchronous-Regulated Nanosheet Cascade Amplifies Sonodynamic-Triggered Self-Enhanced DNA Damage for Intensive Tumor Immunotherapy
Rui Luo, Xinchao Li, Miaomiao Zhang, Dongxue Huang, Hao Le, Tao He, Xiye Wang, Xiaorong Kou, Xinyue Wu, Qinjie Wu et al. · 2025 · ACS Nano
Anomalies de la réparation de l’ADN et cancers gynécologiques
Aurélie Auguste, Alexandra F. Leary · 2017 · Bulletin du Cancer
Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer
Sathya Neelature Sriramareddy, Majeed Jamakhani, L. T. Vilanova, Hélène Brossel, Bernard Staumont, Malik Hamaïdia · 2024 · Frontiers in Oncology
Computational Approaches to Identify Genetic Interactions for Cancer Therapeutics
Graeme Benstead-Hume, Sarah K. Wooller, Frances M. G. Pearl · 2017 · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics
Poly(ADP-Ribose) Polymerase-1 inhibition potentiates cell death and phosphorylation of DNA damage response proteins in oxidative stressed retinal cells
Sandra M. Martín‐Guerrero, Pedro Casado, José Antonio Muñoz‐Gámez, Maria‐Carmen Carrasco, Julio Navascués, Miguel Ángel Cuadros, Juan F. López‐Giménez, Pedro R. Cutillas, David Martín‐Oliva · 2019 · Experimental Eye Research
Identification of exosomes-related lncRNAs in clear cell renal cell carcinoma based on Bayesian spike-and-slab lasso approach
Yali Niu, Xiaocan Jia, Nana Wang, Mengyang Yuan, Ani Dong, Yongli Yang, Xuezhong Shi · 2023 · Functional & Integrative Genomics
Macroscopic inhibition of DNA damage repair pathways by targeting AP-2α with LEI110 eradicates hepatocellular carcinoma
Chenchen Wang, Zhenjun Zhao, Yudong Zhao, Jie Zhao, Lei Xia, Qiang Xia · 2024 · Communications Biology
A Preliminary Study of NER and MMR Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on progression-free survival.
Vahideh Montazeri, Mohammad Hossein Ghahremani, Hamed Montazeri, Mandana Hasanzad, Dornaz Safavi, Mohsen Ayati, Mohammad Chehrazi, Baharak Arefi Moghaddam, Seyed Nasser Ostad · 2020 · PubMed Central
MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes
Xiaoxiao Zhang, Maik Kschischo · 2021 · PLoS ONE
WITHDRAWN: FOXC1 modulates stem-like cell properties and chemoresistance through hedgehog and EMT signaling in gastric adenocarcinoma
Jun Lü, Long‐Long Cao, Yu Xu, Xiaoyan Huang, Soo‐Jeong Cho, Hassan Ashktorab, Duane T. Smoot, Ping Li, Chao‐Hui Zheng, Ji‐Won Kim et al. · 2021 · Molecular Therapy · Retracted
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment
Youyou Zhang, Mu Xu, Jiao Yuan, Zhongyi Hu, Junjie Jiang, Yanrong Sun, Jie Sheng Huang, Yuxin Wang, Bingwei Wang, Jianfeng Shen et al. · 2024 · eLife
Targeting WRN helicase: Discovery and development of its selective inhibitors
Xiangyuan Deng, Cheng Xue, Mi-jia Zhang, Xue Feng, Guogang Zhang · 2025 · Bioorganic Chemistry
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
Bianca Walter, Sophie Hirsch, Laurence Kuhlburger, Aaron Stahl, Leonard Schnabel, Silas Wisser, Lara Annina Haeusser, Foteini Tsiami, Sarah Plöger, Narges Aghaallaei et al. · 2024 · Journal of Experimental & Clinical Cancer Research
New insight into targeting the DNA damage response in the treatment of glioblastoma
Tengfei ZHEN, Tianyu Sun, Baichen XIONG, Hui Liu, Lei Wang, Yao Chen, Haopeng Sun · 2024 · Chinese Journal of Natural Medicines
Discovery of new inhibitors of nuclease MRE11
Fedor Nikulenkov, Benoît Carbain, Raktim Biswas, Štěpán Havel, Jana Prochazkova, Alexandra Sisáková, Magdalena Zacpalova, Melita Chavdarova, Victoria Marini, Vít Všianský et al. · 2025 · European Journal of Medicinal Chemistry
Synthetic Lethal Co-Mutations in DNA Damage Response Pathways Predict Response to Immunotherapy in Pan-Cancer
Lincheng Zhang, Yue Wang, Rong Qiao, Yao Zhang, Huiping Qiang, Huawei Du, Fengcai Wen, Miao Liu, Yan Zhou, Wei Nie et al. · 2025 · JCO Precision Oncology
Aging and biliary tract cancers: Epidemiology, molecular biology, and clinical practice
Xiaoling Weng, Xiaoling Song, Rong Shao, Fatao Liu, Yingbin Liu · 2022 · Aging and Cancer
Combination DNA Damage Response (DDR) Inhibitors to Overcome Drug Resistance in Ovarian Cancer
Dimitrios Nasioudis, Erin M. George, Haineng Xu, Hyoung Kim, Fiona A. Simpkins · 2023 · Cancer treatment and research
Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats
Xinmei Li, Yuandong Zheng, Yifan Zhang, Xia‐Juan Huan, Chen Yang, Meng-ling Liu, Xiaokun Shen, Chunhao Yang, Xingxing Diao · 2022 · Cancer Chemotherapy and Pharmacology
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level
Qi Liu, Kuanyu Wang, Ruoyu Huang, Xuezhi Tong, Tao Jiang, Jiangfei Wang, Pei Yang · 2020 · Journal of Cancer Research and Clinical Oncology
Identification and in silico Analysis of Nonsense SNPs of Human Colorectal Cancer Protein
Lu Wang, Huiyang Tu, Lingzhi Zeng, Ruichen Gao, Sumei Luo, Chao Xiong · 2022 · Journal of Oleo Science
SARS-CoV-2 infection in patients with inborn errors of immunity due to DNA repair defects
Yating Wang, Hassan Abolhassani, Lennart L G Hammarström, Qiang Pan‐Hammarström · 2022 · Acta Biochimica et Biophysica Sinica
Minimizing Bias in Target Selection by Exploiting Multidisciplinary Big Data and the Protein Interactome
Bissan Al‐Lazikani, Paul Workman · 2016 · Future Medicinal Chemistry